Digital transformation for life science innovators
Based in Cambridge, UK, Kymab is a clinical-stage biopharmaceutical company developing a deep pipeline of novel human antibody-based therapies in a broad range of indications. Having raised more than $200 million in funding since its foundation in 2010, Kymab’s unique platforms generate a vast repertoire of fully-human, species cross-reactive and affinity-matured antibodies against challenging targets.
Our extensive experience in designing websites for the life science sector saw Onespacemedia selected by Kymab to reimagine its brand and digital presence. Working in partnership with the Kymab team we modernised Kymab’s brand architecture and designed and built a CMS-powered website that evolves with the changing needs of this pioneering organisation. We continue to work under retainer with Kymab on a combination of design, technical and marketing strategies.
“Onespacemedia’s professional, knowledgeable and understanding approach was essential in helping Kymab to redevelop its website. They rapidly understood our requirements and audiences and developed approaches to satisfy them. Throughout the project all their staff were extremely helpful, going to great lengths to provide solutions to our requests. It was a pleasure to work with them and the outcome is excellent.”
Anne Hyland, CFO, Kymab